Covid-19 Vaccine Responsiveness in MM and Waldenstrom

Clinical trial NCT04830046 · COMPLETED

Trial details

NCT number: NCT04830046
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Myeloma Waldenstrom Macroglobulinemia Immune System Disorder Covid19

Start date: 2021-04-15
Primary completion: 2021-09-14
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.